Technology [ 9/13 ] | Software - Infrastructure [ 90/164 ]
NASDAQ | Common Stock
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.
It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations.
The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities.
In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution.
Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services.
It serves federal and state and local agencies.
The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 9, 24 | 0.00 Decreased by -100.00% | 0.03 Decreased by -100.00% |
| Feb 15, 24 | 0.11 Increased by +37.50% | 0.06 Increased by +83.33% |
| Nov 14, 23 | 0.10 Increased by +900.00% | 0.05 Increased by +100.00% |
| Aug 8, 23 | 0.05 Decreased by -70.59% | 0.02 Increased by +150.00% |
| May 10, 23 | 0.04 Increased by +300.00% | 0.02 Increased by +100.00% |
| Feb 15, 23 | 0.08 Increased by +166.67% | 0.04 Increased by +100.00% |
| Nov 17, 22 | 0.01 Decreased by -87.50% | 0.02 Decreased by -50.00% |
| Aug 11, 22 | 0.17 Increased by +240.00% | 0.03 Increased by +466.67% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 93.01 M Increased by +25.66% | -14.65 M Decreased by -306.94% | Decreased by -15.75% Decreased by -264.68% |
| Sep 30, 23 | 84.18 M Increased by +17.45% | 6.50 M Decreased by -74.10% | Increased by +7.72% Decreased by -77.94% |
| Jun 30, 23 | 76.68 M Increased by +22.55% | -32.35 M Decreased by -197.44% | Decreased by -42.18% Decreased by -179.51% |
| Mar 31, 23 | 71.23 M Increased by +14.18% | -40.60 M Decreased by -173.24% | Decreased by -57.00% Decreased by -164.15% |
| Dec 31, 22 | 74.02 M Increased by +9.00% | 7.08 M Decreased by -86.35% | Increased by +9.56% Decreased by -87.48% |
| Sep 30, 22 | 71.67 M Increased by +8.78% | 25.09 M Increased by +208.29% | Increased by +35.01% Increased by +183.40% |
| Jun 30, 22 | 62.57 M Increased by +5.75% | 33.20 M Increased by +325.82% | Increased by +53.05% Increased by +302.65% |
| Mar 31, 22 | 62.38 M Increased by +17.08% | 55.44 M Increased by +1.44 K% | Increased by +88.86% Increased by +1.22 K% |